Very early researchUnknownNCT05679466
What this trial is testing
An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older
Who this might be right for
Prevention of COVID-19 Caused by SARS-CoV-2
Yu Qin 3,300